Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11586
Title: Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
Authors: Herath, Chandana B;Mak, Kai;Burrell, Louise M;Angus, Peter W
Affiliation: Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Victoria, Australia. cherath@unimelb.edu.au
Issue Date: 18-Oct-2012
Citation: American Journal of Physiology. Gastrointestinal and Liver Physiology 2012; 304(1): G99-108
Abstract: Recent studies have shown that, in cirrhosis, portal angiotensin-(1-7) [Ang-(1-7)] levels are increased and hepatic expression of angiotensin converting enzyme 2 (ACE2) and the Mas receptor are upregulated, but the effects of Ang-(1-7) on hepatic hemodynamics in cirrhosis have not been studied. This study investigated the effects of Ang-(1-7) on vasoconstrictor-induced perfusion pressure increases in cirrhotic rat livers. Ang II or the alpha 1 agonist methoxamine (MTX) were injected in the presence or absence of Ang-(1-7), and the perfusion pressure response was recorded. Denudation of vascular endothelial cells with sodium deoxycholate was used to investigate the contribution of endothelium to the effects of Ang-(1-7). Ang-(1-7) alone had no effect on perfusion pressure. However, it reduced the maximal vasoconstriction response and area under the pressure response curve to Ang II and MTX by >50% (P < 0.05). This effect of Ang-(1-7) was not blocked by Mas receptor inhibition with A779 or by Ang II type 1 and type 2 receptor and bradykinin B(2) receptor blockade and was not reproduced by the Mas receptor agonist AVE0991. D-Pro(7)-Ang-(1-7), a novel Ang-(1-7) receptor antagonist, completely abolished the vasodilatory effects of Ang-(1-7), as did inhibition of endothelial nitric oxide synthase (eNOS) with N(G)-nitro-L-arginine methyl-ester, guanylate cyclase blockade with ODQ and endothelium denudation. The functional inhibition by D-Pro(7)-Ang-(1-7) was accompanied by significant (P < 0.05) inhibition of eNOS phosphorylation. This study shows that Ang-(1-7) significantly inhibits intrahepatic vasoconstriction in response to key mediators of increased vascular and sinusoidal tone in cirrhosis via a receptor population present on the vascular endothelium that is sensitive to D-Pro(7)-Ang-(1-7) and causes activation of eNOS and guanylate cyclase-dependent NO signaling pathways.
Internal ID Number: 23086915
URI: http://ahro.austin.org.au/austinjspui/handle/1/11586
DOI: 10.1152/ajpgi.00163.2012
URL: http://www.ncbi.nlm.nih.gov/pubmed/23086915
Type: Journal Article
Subjects: Angiotensin I.pharmacology
Angiotensin II.pharmacology
Animals
Blood Pressure.drug effects
Blotting, Western
Endothelium, Vascular.metabolism.physiology
In Situ Hybridization
Liver.metabolism.pathology
Liver Circulation.drug effects
Liver Cirrhosis.pathology.physiopathology
Male
Methoxamine.antagonists & inhibitors.pharmacology
Nitric Oxide.physiology
Nitric Oxide Synthase Type III.metabolism
Peptide Fragments.pharmacology
Phosphorylation
Rats
Rats, Sprague-Dawley
Receptor, Angiotensin, Type 1.drug effects
Receptor, Angiotensin, Type 2.drug effects
Receptor, Bradykinin B2.drug effects
Vasoconstrictor Agents.antagonists & inhibitors.pharmacology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.